drugset / Trial / NCT06967376
The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis
RandomizedParallel-groupSingle-blindTreatment
Summary
This was a prospective, single centre, randomised controlled study to evaluate the clinical effectiveness of corneal collagen crosslinking as an adjuvant to antimicrobial therapy.
Timeline
- Start
- 2018-05-21
- Primary completion
- 2021-11-11
- Completion
- 2022-02-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ceftazidime | Small molecule | 50 mg/ml | Topical |
| Comparator | Itraconazole | Small molecule | 100 mg | Oral |
| Comparator | Vancomycin | Other / unclassified | 50 mg/ml | Topical |